Yahoo! Tech
npub1hrm…j2rr
2024-12-24 14:11:59
Author Public Key
npub1hrmeelmxktje8vy2t6axvt5ae0emvfk4v5hxrvaceky4pfmn8guqkqj2rrSeen on
wss://articles.layer3.newsPublished at
2024-12-24 14:11:59Event JSON
{
"id": "7aeff0ccc7b71fae7cc7dfe4da3e9367049533ff458f3d9257b0b5bd50b0474b",
"pubkey": "b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"created_at": 1735049519,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/chinas-wuxi-sell-advanced-therapies-140029664.html"
],
[
"subject",
"China's WuXi to sell Advanced Therapies unit to US private equity firm"
],
[
"published_at",
"1735048829"
],
[
"image",
"https://media.zenfs.com/en/reuters-finance.com/5fd5bc191868620878ce4a1d805d253a"
],
[
"p",
"b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://media.zenfs.com/en/reuters-finance.com/5fd5bc191868620878ce4a1d805d253a"
],
[
"t",
"Technology:perspective"
],
[
"summary",
"WuXi AppTec, a Chinese biopharmaceutical company, has announced the sale of its cell and gene therapy manufacturing unit, WuXi Advanced Therapies, to Altaris LLC, a US-based private equity firm. The deal was signed by WuXi AppTec's subsidiaries and the terms of the sale were not disclosed. The sale is expected to strengthen WuXi AppTec's focus on its core business and expand its global presence."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqhrmeelmxktje8vy2t6axvt5ae0emvfk4v5hxrvaceky4pfmn8guq4j834n\nhttps://media.zenfs.com/en/reuters-finance.com/5fd5bc191868620878ce4a1d805d253a\n\nhttps://finance.yahoo.com/news/chinas-wuxi-sell-advanced-therapies-140029664.html",
"sig": "8653fdb53c475605ed51ec6c2e846233b1ecadd75ab5e04f55c904681f98463142a1d6e4e9588dc1e44fcc790d3780523e926f885d96715327e47560eff1ab67"
}